Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/SyndromesdRecommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

被引：1

作者：

Aakash, Fnu ^{[1
,2
]}

Gisriel, Savanah D. ^{[3
,4
]}

Zeidan, Amer M. ^{[5
]}

Bennett, John M. ^{[6
]}

Bejar, Rafael ^{[7
]}

Bewersdorf, Jan Philipp ^{[8
]}

Borate, Uma M. ^{[9
]}

Boultwood, Jacqueline ^{[10
]}

Brunner, Andrew M. ^{[11
]}

Buckstein, Rena ^{[12
]}

Carraway, Hetty E. ^{[13
]}

Churpek, Jane E. ^{[14
]}

Daver, Naval G. ^{[15
]}

Dezern, Amy E. ^{[16
]}

Efficace, Fabio ^{[17
]}

Fenaux, Pierre ^{[18
]}

Figueroa, Maria E. ^{[19
]}

Garcia-Manero, Guillermo ^{[15
]}

Gore, Steven D. ^{[20
]}

Greenberg, Peter L. ^{[21
]}

Griffiths, Elizabeth A. ^{[22
]}

Halene, Stephanie ^{[5
]}

Hourigan, Christopher S. ^{[23
]}

Kim, Tae Kon ^{[24
]}

Kim, Nina ^{[25
]}

Komrokji, Rami S. ^{[26
]}

Kutchroo, Vijay K. ^{[27
]}

List, Alan F. ^{[28
]}

Little, Richard F. ^{[20
]}

Majeti, Ravindra ^{[21
]}

Nazha, Aziz ^{[29
]}

Nimer, Stephen D. ^{[30
]}

Odenike, Olatoyosi ^{[31
,32
]}

Padron, Eric ^{[26
]}

Patnaik, Mrinal M. ^{[33
]}

Platzbecker, Uwe ^{[34
]}

Porta, Matteo G. Della ^{[35
]}

Roboz, Gail J. ^{[36
,37
]}

Sallman, David A. ^{[26
]}

Santini, Valeria ^{[38
]}

Sanz, Guillermo ^{[39
,40
,41
]}

Savona, Michael R. ^{[24
]}

Sekeres, Mikkael A. ^{[30
]}

Stahl, Maximilian ^{[42
]}

Starczynowski, Daniel T. ^{[43
]}

Steensma, David P. ^{[44
]}

Taylor, Justin ^{[30
]}

Abdel-Wahab, Omar ^{[8
]}

Wei, Andrew H. ^{[45
]}

Xie, Zhuoer ^{[26
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[2] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA

[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT USA

[4] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA

[5] Yale Sch Med, Yale Canc Ctr, Dept Internal Med, Sect Hematol,Sch Med, New Haven, CT USA

[6] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Div Hematopathol, Rochester, NY USA

[7] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA

[9] Ohio State Univ, Div Hematol, Comprehens Canc Ctr, Columbus, OH USA

[10] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England

[11] Brigham & Womens Hosp, Div Hematol, Boston, MA USA

[12] Sunnybrook Hlth Sci Ctr, Dept Med, Div Med Oncol Hematol, Toronto, ON, Canada

[13] Cleveland Clin, Leukemia Program, Taussig Canc Inst, Hematol & Med Oncol, Cleveland, OH USA

[14] Univ Wisconsin Madison, Carbone Canc Ctr, Div Haematol Oncol & Palliat Care, Madison, WI 53706 USA

[15] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[16] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[17] Italian Grp Adult Hematol Dis GIMEMA, Hlth Outcomes Res Unit, Rome, Italy

[18] Univ Paris Cite, Serv Hematol, Paris, France

[19] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA

[20] NCI, Canc Therapy Evaluat Program, Rockville, MD USA

[21] Stanford Univ, Stanford Canc Inst, Sch Med, Dept Med,Div Hematol, Stanford, CA USA

[22] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[23] Virginia Tech, Fralin Biomed Res Inst, FBRI Canc Res Ctr, Washington, DC USA

[24] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA

[25] NCI, NIH, Bethesda, MD USA

[26] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Program, Tampa, FL USA

[27] Brigham & Womens Hosp, Boston, MA USA

[28] New York Infirm, New York, NY USA

[29] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA

[30] Univ Miami, Dept Med, Div Hematol, Div Hematol,Miller Sch Med, Miami, FL USA

[31] Univ Chicago, Sect Hematol Oncol, Leukemia Program, Chicago, IL 60637 USA

[32] Univ Chicago, Comprehens Canc Ctr, Chicago, IL USA

[33] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA

[34] Univ Hosp Leipzig, Dept Hematol & Cellular Therapy, Leipzig, Germany

[35] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[36] New York Acad Med, New York, NY USA

[37] New York Presbyterian Hosp, New York, NY USA

[38] Univ Florence, Dept Expt & Clin Med, Myelodysplast Syndromes Unit, Hematol,Azienda Osped Univ Careggi, Florence, Italy

[39] Hlth Res Inst La Fe, Valencia, Spain

[40] Hosp Univ & Politecn La Fe, Valencia, Spain

[41] ISCarlosIII, CIBERONC, Madrid, Spain

[42] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Div Leukemia, Boston, MA USA

[43] Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Cincinnati, OH USA

[44] David Steensma LLC, Cambridge, MA USA

[45] Royal Melbourne Hosp, Dept Haematol Lab, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia

[46] Massachusetts Gen Hosp Brigham, Dept Pathol, Boston, MA USA

来源：

MODERN PATHOLOGY | 2024年 / 37卷 / 12期

关键词：

icMDS; MDS; myelodysplastic neoplasms; myelodysplastic syndromes; classification; diagnosis; HEALTH-ORGANIZATION CLASSIFICATION; FLOW-CYTOMETRY; COPPER DEFICIENCY; 5TH EDITION; MUTATIONS; VALIDATION; RISK; ABNORMALITIES; EVOLUTION; LEUKEMIA;

D O I：

10.1016/j.modpat.2024.100615

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of biologically distinct entities characterized by variable degrees of ineffective hematopoiesis. Recently, 2 classification systems (the 5th edition of the World Health Organization Classification of Haematolymphoid tTumours and the International Consensus Classification) further subcharacterized MDS into morphologically and genetically defined groups. Accurate diagnosis and subclassification of MDS require a multistep systemic approach. The International Consortium for MDS (icMDS) summarizes a contemporary, practical, and multimodal approach to MDS diagnosis and classification. (c) 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

引用

页数：13

共 50 条

[1] Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Stahl, Maximilian
Bewersdorf, Jan Philipp
Xie, Zhuoer
Porta, Matteo Giovanni Della
Komrokji, Rami
Xu, Mina L.
Abdel-Wahab, Omar
Taylor, Justin
Steensma, David P.
Starczynowski, Daniel T.
Sekeres, Mikkael A.
Sanz, Guillermo
Sallman, David A.
Roboz, Gail J.
Platzbecker, Uwe
Patnaik, Mrinal M.
Padron, Eric
Odenike, Olatoyosi
Nimer, Stephen D.
Nazha, Aziz
Majeti, Ravi
Loghavi, Sanam
Little, Richard F.
List, Alan F.
Kim, Tae Kon
Hourigan, Christopher S.
Hasserjian, Robert P.
Halene, Stephanie
Griffiths, Elizabeth A.
Gore, Steven D.
Greenberg, Peter
Figueroa, Maria E.
Fenaux, Pierre
Efficace, Fabio
Dezern, Amy E.
Daver, Naval G.
Churpek, Jane E.
Carraway, Hetty E.
Buckstein, Rena
Brunner, Andrew M.
Boultwood, Jacqueline
Borate, Uma
Bejar, Rafael
Bennett, John M.
Wei, Andrew H.
Santini, Valeria
Savona, Michael R.
Zeidan, Amer M.
BLOOD REVIEWS, 2023, 62
[2] Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)
Lanino, Luca
Ball, Somedeb
Bewersdorf, Jan Philipp
Marchetti, Monia
Travaglino, Erica
Al Ali, Najla H.
Fenaux, Pierre
Platzbecker, Uwe
Santini, Valeria
Diez-Campelo, Maria
Singh, Avani M.
Jain, Akriti Gupta
Aguirre, Luis E.
Tinsley-Vance, Sara M.
Schwabkey, Zaker I.
Chan, Onyee
Xie, Zhuoer
Brunner, Andrew M.
Kuykendall, Andrew T.
Bennett, John M.
Buckstein, Rena
Bejar, Rafael
Carraway, Hetty E.
DeZern, Amy E.
Griffiths, Elizabeth A.
Halene, Stephanie
Hasserjian, Robert
Lancet, Jeffrey
List, Alan F.
Loghavi, Sanam
Odenike, Olatoyosi
Padron, Eric
Patnaik, Mrinal M.
Roboz, Gail J.
Stahl, Maximilian
Sekeres, Mikkael A.
Steensma, David Peter
Savona, Michael R.
Taylor, Justin
Xu, Mina
Sweet, Kendra
Sallman, David A.
Nimer, Stephen D.
Hourigan, Christopher S.
Wei, Andrew H.
Sauta, Elisabetta
D'Amico, Saverio
Asti, Gianluca
Castellani, Gastone
Borate, Uma M.
BLOOD, 2023, 142
[3] Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Bewersdorf, Jan Philipp
Xie, Zhuoer
Bejar, Rafael
Borate, Uma
Boultwood, Jacqueline
Brunner, Andrew M.
Buckstein, Rena
Carraway, Hetty E.
Churpek, Jane E.
Daver, Naval G.
Della Porta, Matteo Giovanni
DeZern, Amy E.
Fenaux, Pierre
Figueroa, Maria E.
Gore, Steven D.
Griffiths, Elizabeth A.
Halene, Stephanie
Hasserjian, Robert P.
Hourigan, Christopher S.
Kim, Tae Kon
Komrokji, Rami
Kuchroo, Vijay K.
List, Alan F.
Loghavi, Sanam
Majeti, Ravindra
Odenike, Olatoyosi
Patnaik, Mrinal M.
Platzbecker, Uwe
Roboz, Gail J.
Sallman, David A.
Santini, Valeria
Sanz, Guillermo
Sekeres, Mikkael A.
Stahl, Maximilian
Starczynowski, Daniel T.
Steensma, David P.
Taylor, Justin
Abdel-Wahab, Omar
Xu, Mina L.
Savona, Michael R.
Wei, Andrew H.
Zeidan, Amer M.
BLOOD REVIEWS, 2023, 60
[4] Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
Efficace, Fabio
Buckstein, Rena
Abel, Gregory A.
Giesinger, Johannes M.
Fenaux, Pierre
Bewersdorf, Jan Philipp
Brunner, Andrew M.
Bejar, Rafael
Borate, Uma
DeZern, Amy E.
Greenberg, Peter
Roboz, Gail J.
Savona, Michael R.
Sparano, Francesco
Boultwood, Jacqueline
Komrokji, Rami
Sallman, David A.
Xie, Zhuoer
Sanz, Guillermo
Carraway, Hetty E.
Taylor, Justin
Nimer, Stephen D.
Della Porta, Matteo Giovanni
Santini, Valeria
Stahl, Maximilian
Platzbecker, Uwe
Sekeres, Mikkael A.
Zeidan, Amer M.
HEMASPHERE, 2024, 8 (05):
[5] Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Hebeda K.M.
Fend F.
Journal of Hematopathology, 2009, 2 (4) : 205 - 210
[6] Study Highlights Difficulties in the Diagnosis of Myelodysplastic Neoplasms (MDS)
Girton, Mark R.
CLINICAL CHEMISTRY, 2024, 70 (06) : 885 - 886
[7] An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Savona, Michael R.
Malcovati, Luca
Komrokji, Rami
Tiu, Ramon V.
Mughal, Tariq I.
Orazi, Attilio
Kiladjian, Jean-Jacques
Padron, Eric
Solary, Eric
Tibes, Raoul
Itzykson, Raphael
Cazzola, Mario
Mesa, Ruben
Maciejewski, Jaroslaw
Fenaux, Pierre
Garcia-Manero, Guillermo
Gerds, Aaron
Sanz, Guillermo
Niemeyer, Charlotte M.
Cervantes, Francisco
Germing, Ulrich
Cross, Nicholas C. P.
List, Alan F.
BLOOD, 2015, 125 (12) : 1857 - 1865
[8] Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance
Hoff, Fieke W.
Madanat, Yazan F.
CELLS, 2023, 12 (04)
[9] Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
Lee, Wan-Hsuan
Lin, Chien-Chin
Tsai, Cheng-Hong
Tien, Feng-Ming
Lo, Min-Yen
Tseng, Mei-Hsuan
Kuo, Yuan-Yeh
Yu, Shan-Chi
Liu, Ming-Chih
Yuan, Chang-Tsu
Yang, Yi-Tsung
Chuang, Ming-Kai
Ko, Bor-Sheng
Tang, Jih-Luh
Sun, Hsun-, I
Chuang, Yi-Kuang
Tien, Hwei-Fang
Hou, Hsin-An
Chou, Wen-Chien
BLOOD CANCER JOURNAL, 2024, 14 (01)
[10] Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogenetique hematologique (GFCH)
Auger, Nathalie
Douet-Guilbert, Nathalie
Quessada, Julie
Theisen, Olivier
Lafage-Pochitaloff, Marina
Troadec, Marie-Berengere
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)

← 1 2 3 4 5 →